Ledger.Open graph →
SEC Form D · filed February 7, 2022

Rgenta Therapeutics, Inc

Offering
$8.9M
Sold
$8.9M
Exemption
Rule 506(b)
Industry
Other
Location
Woburn, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Sun S. Linghao · Woburn, MADirectorHualin S. Xi · Woburn, MAExec · DirectorTravis S. Wager · Woburn, MAExecZhiping S. Weng · Woburn, MADirectorJudith S. Li · Cambridge, MADirectorFei S. Shen · Woburn, MADirectorDebasish S. Roychowdhury · Cambridge, MADirectorHongbo S. Lu · Cambridge, MADirectorJudith S. Li · Cambridge, MADirectorSun S. Linghao · Woburn, MADirectorHualin S. Xi · Woburn, MAExec · DirectorFei S. Shen · Woburn, MADirectorDebasish S. Roychowdhury · Cambridge, MADirectorHongbo S. Lu · Cambridge, MADirectorTravis S. Wager · Woburn, MAExecZhiping S. Weng · Woburn, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗